Burden of psychiatric disorders in the pediatric population

European Neuropsychopharmacology

Volumn 23, Issue 2, 2013, Pages 98-106

  Clavenna, Antonio ^a   Cartabia, Massimo ^a   Sequi, Marco ^a   Costantino, Maria Antonella ^b   Bortolotti, Angela ^c   Fortino, Ida ^c   Merlino, Luca ^c   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Regional Health Ministry   (Italy)

Author keywords

Adolescent; Child; Delivery of health care; Mental disorders; Psychotropic drugs

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CHLORPROMAZINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PIMOZIDE; RISPERIDONE; SERTRALINE; VENLAFAXINE;

ADULT; AMBULATORY CARE; ANXIETY DISORDER; ARTICLE; DEVELOPMENTAL DISORDER; EATING DISORDER; FEMALE; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROPSYCHIATRY; PEDIATRICS; POPULATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SEX DIFFERENCE; SUBSTANCE ABUSE;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; ITALY; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; NATIONAL HEALTH PROGRAMS; PRESCRIPTION DRUGS; PREVALENCE; SEX CHARACTERISTICS;

EID: 84873526166     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.04.008     Document Type: Article

References (49)

1. Acquaviva E., Legleye S., Auleley G.R., Deligne J., Carel D., Falissard B.B. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry 2009, 9:72.
2. Alighieri S., Favero F., Polmonari A., Pedrini L., Alvarez M., Calati R., Desideri L., Durante D., Ro L., Magnani G., Micheletti S., Pericoli V., Preti A., Raimondi E., Raggini R., Riboni V., Scaduto M.C., Sisti D., Rocchi M.B.L., De Girolamo G. Le caratteristiche strutturali e le variabili di processo dei servizi di neuropsichiatria dell'Infanzia e dell'Adolescenza in Italia: uno studio regionale. Giorn. Neuropsich. Età Evol. 2011, 31:1-11.
3. American Academy of Pediatrics ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011, 128:1007-1022.
4. Barbui C., Tansella M. Thirtieth birthday of the Italian psychiatric reform: research for identifying its active ingredients is urgently needed. J. Epidemiol. Community Health 2008, 62:1021.
5. Belfer M.L. Child and adolescent mental disorders: the magnitude of the problem across the globe. J. Child Psychol. Psychiatry 2008, 49:226-236.
6. Brocco S., Visentin C., Fedeli U., Schievano E., Avogaro A., Andretta M., Avossa F., Spolaore P. Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc. Diabetol. 2007, 6:5.
7. Calderoni D., Ferrara M., Sarti M.I., Nardocci F. "More with less": minori e ricovero psichiatrico. Gior. Neuropsich. Età Evol. 2008, 28:149-166.
8. Case B.G., Olfson M., Marcus S.C., Siegel C. Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000. Arch. Gen. Psychiatry 2007, 64:89-96.
9. Clavenna A., Andretta M., Pilati P., Dusi M., Gangemi M., Gattoni M.B., Lombardo G., Zoccante L., Mezzalira L., Bonati M. Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatr. 2011, 11:40.
10. Clavenna A., Bonati M. Antidepressant prescriptions in paediatric outpatients in Europe. Paediatr. Perinat. Drug Ther. 2007, 8:103-108.
11. Clavenna A., Rossi E., De Rosa M., Bonati M. Use of psychotropic medications in Italian children and adolescents. Eur. J. Pediatr. 2007, 166:339-347.
12. Costello E.J., Egger H., Angold A. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden. J. Am. Acad. Child Adolescent Psychiatry 2005, 44:972-986.
13. Costello E.J., Mustillo S., Erkanli A., Keeler G., Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 2003, 60:837-844.
14. Didoni A., Sequi M., Panei P., Bonati M. 2011. One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder. Eur. J. Clin. Pharmacol. 67, 1061-1067.
15. Frigerio A., Rucci P., Goodman R., Ammaniti M., Carlet O., Cavolina P., De Girolamo G., Lenti C., Lucarelli L., Mani E., Martinuzzi A., Micali N., Milone A., Morosini P., Muratori F., Nardocci F., Pastore V., Polidori G., Tullini A., Vanzin L., Villa L., Walder M., Zuddas A., Molteni M. Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study. Eur. Child Adolescent Psychiatry 2009, 18:217-226.
16. Giarrizzo M.L., Pezzotti P., Silvestri I., Di Lallo D. Stima di prevalenza di diabete mellito in una provincia del Lazio attraverso i modelli cattura e ricattura. Epidemiol. Prev. 2007, 31:333-339.
17. Hammad T.A., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 2006, 63:332-339.
18. Istituto Superiore di Sanità, Agenzia Italiana del Farmaco Protocollo diagnostico e terapeutico della sindrome da iperattività e deficit di attenzione per il registro nazionale ADHD 2007, Istituto Superiore di Sanità, Roma.
19. Jensen P.S., Goldman E., Offord D., Costello E.J., Friedman R., Huff B., Crowe M., Amsel L., Bennett K., Bird H., Conger R., Fisher P., Hoagwood K., Kessler R.C., Roberts R. Overlooked and underserved: "action signs" for identifying children with unmet mental health needs. Pediatrics 2011, 128:970-979.
20. Jutte D.P., Roos L.L., Brownell M.D. Administrative record linkage as a tool for public health research. Annu. Rev. Public Health 2011, 32:91-108.
21. Maughan B., Collishaw S., Meltzer H., Goodman R. Recent trends in UK child and adolescent mental health. Soc. Psychiatry Psychiatr. Epidemiol. 2008, 43:305-310.
22. Ministero della Salute Nuove informazioni sulla sicurezza delle specialitα medicinali contenenti paroxetina nel trattamento della malattia depressiva nei bambini e adolescenti al di sotto di 18 anni. Boll. Informazione sui Farm. 2003, 5-6:207.
23. Mitchell B., Carleton B., Smith A., Prosser R., Brownell M., Kozyrskyj A. Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces. Can. J. Psychiatry 2008, 53:152-159.
24. Monte S., Macchia A., Romero M., D'Ettorre A., Giuliani R., Tognoni G. Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk. Eur. J. Clin. Pharmacol. 2009, 65:1131-1138.
25. Morris J., Belfer M., Daniels A., Flisher A., Ville L., Lora A., Saxena S. Treated prevalence of and mental health services received by children and adolescents in 42 low-and-middle-income countries. J. Child Psychol. Psychiatry 2011, 52:1239-1246.
26. Nardocci F. The birth of child and adolescent neuropsychiatry: from rehabilitation and social inclusion of the mentally handicapped, to the care of mental health during development. Ann. Ist. Super. Sanita. 2009, 45:33-38.
27. National Collaborating Centre For Mental Health Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults 2008, NICE, London.
28. Olfson M., Marcus S.C. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 2009, 66:848-856.
29. Panei P., Arcieri R., Vella S., Bonati M., Martini N., Zuddas A. Italian attention-deficit/hyperactivity disorder registry. Pediatrics 2004, 114:514.
30. Percudani M., Barbui C., Fortino I., Petrovich L. Antidepressant drug use in Lombardy, Italy: a population-based study. J. Affective Disord. 2004, 83:169-175.
31. Percudani M., Barbui C., Fortino I., Petrovich L. Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother. Psychosom. 2005, 74:189-190.
32. Poluzzi E., Piccinni C., Carta P., Puccini A., Lanzoni M., Motola D., Vaccheri A., De P.F., Montanaro N. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study. Eur. J. Clin. Pharmacol. 2011, 67:407-414.
33. Preen D.B., Calver J., Sanfilippo F.M., Bulsara M., Holman C.D. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed. Aust. N. Z. J. Public Health 2007, 31:120-126.
34. Ravens-Sieberer U., Wille N., Erhart M., Bettge S., Wittchen H.U., Rothenberger A., Herpertz-Dahlmann B., Resch F., Holling H., Bullinger M., Barkmann C., Schulte-Markwort M., Dopfner M. Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey. Eur. Child Adolescent Psychiatry 2008, 17(Suppl. 1):22-33.
35. Saxena S., Thornicroft G., Knapp M., Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007, 370:878-889.
36. Sevilla-Dedieu C., Kovess-Masfety V. Psychotropic medication use in children and adolescents: a study from France. J. Child Adolescent Psychopharmacol. 2008, 18:281-289.
37. Sourander A., Helstela L., Ristkari T., Ikaheimo K., Helenius H., Piha J. Child and adolescent mental health service use in Finland. Soc. Psychiatry Psychiatr. Epidemiol. 2001, 36:294-298.
38. Tessari R., Migliore E., Balzi D., Barchielli A., Canova C., Faustini A., Galassi C., Simonato L. Stima della prevalenza dell'asma bronchiale basata su dati sanitari correnti mediante un algoritmo comune in differenti aree italiane. Epidemiol. Prev. 2008, 32:56-65.
39. Tournier M., Greenfield B., Galbaud du F.G., Ducruet T., Zito J.M., Cloutier A.M., Moride Y. Patterns of antidepressant use in Quebec children and adolescents: trends and predictors. Psychiatry Res. 2010, 179:57-63.
40. Usala T., Clavenna A., Zuddas A., Bonati M. 2007. Randomised controlled trials of Selective Serotonin Reuptake Inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 18, 62-73.
41. Vinker S., Vinker R., Elhayany A. Prevalence of methylphenidate use among Israeli children: 1998-2004. Clin. Drug Invest. 2006, 26:161-167.
42. Volkers A.C., Heerdink E.R., van Dijk L. Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol. Drug Saf. 2007, 16:1054-1062.
43. World Health Organization Atlas: Child and Adolescent Mental Health Resources: Global Concerns, Implications for the Future 2005, World Health Organization, Geneva.
44. World Health Organization The Global Burden of Disease. 2004 Update 2008, World Health Organization, Geneva.
45. World Health Organization Regional Office for Europe The European Health Report 2005: Public Health Action for Healthier Children and Populations 2005, World Health Organization, Copenhagen.
46. Zito J.M., Safer D.J., de Jong-van den Berg L.T., Janhsen K., Fegert J.M., Gardner J.F., Glaeske G., Valluri S.C. A three-country comparison of psychotropic medication prevalence in youth. Child Adolescent Psychiatry Ment. Health 2008, 2:26.
47. Zoega H., Baldursson G., Hrafnkelsson B., Almarsdottir A.B., Valdimarsdottir U., Halldorsson M. Psychotropic drug use among Icelandic children: a nationwide population-based study. J. Child Adolescent Psychopharmacol. 2009, 19:757-764.
48. Zoega H., Furu K., Halldorsson M., Thomsen P.H., Sourander A., Martikainen J.E. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr. Scand. 2011, 123:360-367.
49. Zuvekas S.H., Vitiello B. Stimulant medication use in children: a 12-year perspective. Am. J. Psychiatry 2012, 169:160-166.